Home » Topics » Regulatory

Regulatory
RSS

FDA approves Allergan's Ozurdex for macular edema following retinal vein occlusion

June 22, 2009

FDA approves Novartis' monoclonal antibody Ilaris for children and adults with CAPS

June 18, 2009

FDA approves Besivance for bacterial conjunctivitis

June 2, 2009

European Commission grants marketing authorization to HRA Pharma's ellaOne

May 27, 2009

FDA approves Adcirca tablets for pulmonary arterial hypertension

May 27, 2009

FDA approves Otsuka's Samsca for hypervolemic and euvolemic hyponatremia

May 22, 2009

European Commission approves Qutenza for peripheral neuropathic pain

May 22, 2009

FDA approves UCB's pegylated anti-TNF Cimzia for rheumatoid arthritis

May 14, 2009

FDA grants marketing approval to Vanda's Fanapt for schizophrenia

May 7, 2009

FDA approves Novartis' combination drug Exforge HCT for high blood pressure

May 4, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...